Insulin production involves complex biochemical processes, where enzymes act as biological catalysts to facilitate these reactions. Recombinant DNA technology, which relies on catalytic enzymes, is often used to produce synthetic insulin. This has been a breakthrough for diabetes management, making insulin therapy more accessible and effective.
